Changchun Deng

2PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 30, 2026
A phase 1, first-in-human study of safimaltib, a MALT1 inhibitor, in B-lymphocytic malignancies.

|Oct 28, 2016
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies.

Changchun Deng, Mark R Lipstein, Luigi Scotto

Pageof 1

Frequent Collaborators

1 joint publications

Mark Hertzberg

1 joint publications

Chan Y Cheah

1 joint publications

Stephen Opat

1 joint publications

Matko Kalac